Profile
VIRI VRTX REGN SGEN ALNY ARGX
Company Name Virios Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $206.50K $116.96B $55.30B $43.15B $41.50B $33.28B
Employees 0.00K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Gregory Duncan Dr. Reshma Kewalramani FASN, M.D. Leonard S. Schleifer David R. Epstein Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
VIRI VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 2
Quant Rating Sell Sell Buy Neutral Strong Sell Sell
Trading
VIRI VRTX REGN SGEN ALNY ARGX
Last Close $0.155 $457.03 $547.74 $228.74 $329.77 $545.11
High 52 $0.29 $516.74 $1201.76 $228.74 $329.77 $671.75
Low 52 $0.14 $396.64 $482.92 $228.74 $224.58 $435.29
Price vs. 52 Week High -46.55 % -11.56 % -54.42 % 0 % 0 % -18.85 %
Price vs. 52 Week Low 10.71 % 15.23 % 13.42 % 0 % 46.84 % 25.23 %
Total Return
VIRI VRTX REGN SGEN ALNY ARGX
1 Month Return 0 % 2.36 % 12.32 % 0 % 8.53 % -5.46 %
3 Month Return 0 % -5.57 % -10.24 % 0 % 25.81 % -7.43 %
6 Month Return 0 % 12.26 % -23.73 % 0 % 40.76 % -12.18 %
9 Month Return -1.15 % 0.77 % -46.01 % 0 % 22.35 % 0.39 %
YTD Return 0 % 13.49 % -23.11 % 0 % 40.14 % -11.36 %
1 Year Return -35.44 % -2.82 % -46.51 % 0 % 32.61 % 25.23 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
VIRI VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.34 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -7.61 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) -7.07 % - 2.08 % - - -
Growth
VIRI VRTX REGN SGEN ALNY ARGX
Asset Growth -100 % -0.87 % 36.55 %
Gross Profit Growth - 10.25 % 77.08 %
Revenue Growth - 11.66 % 78.6 %
Revenue 3 Year - 45.6 % 275.84 %
Revenue 5 Year - 163.93 % 1701.04 %
Revenue 10 Year - 1632.15 % 5950.81 %
EBIT Growth - -93.69 % 128.87 %
Net Income Growth -472808.95 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share -19153.8 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share -64292.37 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share -84252.55 % 33.84 % 938.02 %
Operating Income Growth -305706.33 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) -180391.22 % -113.93 % 80.31 %
Operating 3 Year CFG -6774.6 % -118.65 % 88.36 %
Operating 5 Year CFG -29810.8 % -131.3 % -135.21 %
Operating 10 Year CFG -52224.66 % 12.43 % -64 %
EPS Growth -131660.71 % -114.8 % 369.77 %
EPS Diluted Growth -131660.71 % -114.97 % 347.67 %
Book Value Per Share -100 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -100 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share 100 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 100 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth - 116.42 % 95.27 %
Free Cash Flow Growth -180391.22 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
VIRI VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -25.82 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -1412.79 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -17.64 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 108.49 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 138.59 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -7044.33 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM - 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM - 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -198.45 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -198.45 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 25836.03 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -7044.33 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM - -92.97 18.31 -81.26 -550.45 -434.25
Price To Operating Cash Flows Ratio TTM - -119.36 14.06 -93.1 -914.84 -515.98
Price Cash Flow Ratio TTM - -119.36 14.06 -93.1 -914.84 -515.98
Income Statement (TTM)
VIRI VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-17.39B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-25.05B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -368.93 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
VIRI VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
VIRI VRTX REGN SGEN ALNY ARGX
Net Income $-12.35B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $-0.51B $0B $0B $0B $0B $0B
Operating Cash Flow $-8.79B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.85
AARD Aardvark Therapeutics, Inc. Common Stock 13.52
ABCL AbCellera Biologics Inc. 3.75
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.87
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.13
ABPWW 0.0222
ABSI Absci Corporation 2.69
ABUS Arbutus Biopharma Corporation 3.19
ABVC ABVC BioPharma, Inc. 3.1
ABVX Abivax SA American Depositary Shares 7.76
ACAD ACADIA Pharmaceuticals Inc. 21.24
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.614
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.26
ACIU AC Immune SA 2.02
ETFs With Exposure to VIRI
Ticker ETF Name Weight Percentage Price
VEA Vanguard Developed Markets Index Fund 0.00174 57.15
VGK Vanguard European Stock Index Fund 0.00321 77.79
VT Vanguard Total World Stock Index Fund 0.00047 129.11
VXUS Vanguard Total Intl Stock Idx Fund 0.00125 69.33
SPDW SPDR Portfolio Developed World ex-US ETF 0.001728 40.58
VSS Vanguard FTSE All-World ex-US Small Capital Index Fund 0.01307 134.72
GWX SPDR S&P International Small Cap ETF 0.010807 37.25
SCHC Schwab International Small-Cap Equity ETF 0.0197682 42.68
VXF Vanguard Extended Market Index Fund 0 195.67
IWC iShares Micro-Cap ETF 0 131.5
FNDC Schwab Fundamental International Small Company Index ETF 0.0259524 42.25
VE.TO Vanguard FTSE Developed Europe All Cap Index ETF 0.00246 41.11
SPEU SPDR Portfolio Europe ETF 0.002959 48.63
AVDE Avantis International Equity ETF 0 74.17
VTSNX Vanguard Total Intl Stock Idx Fund 0 148.93
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 148.44
VFSAX Vanguard FTSE All-World ex-US Small-Cap Index Fund Admiral Shares 0.01307 33.25
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 148.45
VTMNX Vanguard Developed Markets Index Fund Institutional Shares 0.00174 18.39
VEUSX Vanguard European Stock Index Fund Admiral Shares 0.00321 97.24
VTIAX Vanguard Total International Stock Index Fd Admiral 0.00125 37.24
VTWAX Vanguard Total World Stock Index Fund Admiral Shares 0.00047 45.71
VTMGX Vanguard Developed Markets Index Admiral 0.00174 18.37
VDIPX Vanguard Developed Markets Index Fund 0 28.75
VEMPX Vanguard Extended Market Index InstlPlus 0 366.31
VTWIX Vanguard Total World Stock Index I 0.00047 263.5
VTPSX Vanguard Total Intl Stock Idx InstlPls 0.00125 148.97
AVDS Avantis International Small Cap Equity ETF 0.02 62.43
Unlock